RecruitingNCT05848297

Automated Robotic TCD in Traumatic Brain Injury

Automated Robotic TCD in Traumatic Brain Injury (ART-TBI)


Sponsor

Virginia Commonwealth University

Enrollment

30 participants

Start Date

May 20, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcranial Doppler ultrasonography (TCD) for people with brain injuries, traumatic. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Doppler ultrasonography (TCD)

Portable, bedside, non-invasive diagnostic tool used for real-time assessment of cerebral hemodynamics


Locations(3)

University of California, Davis

Davis, California, United States

Wake Forest University

Winston-Salem, North Carolina, United States

Virginia Commonwealth University

Richmond, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05848297


Related Trials